Browse > Article

Case Report of Diabetic Neuropathy Treated with Palmijihwang-tang, Acupuncture, and Moxibustion  

Woo, Ji-myung (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Kang, Ah-reum (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Lee, Mi-rim (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Kim, Su-bin (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Jung, Woo-sang (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Moon, Sang-kwan (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Cho, Ki-ho (Dept. of Cardiology and Neurology, Graduate School, Kyung Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.37, no.2, 2016 , pp. 232-236 More about this Journal
Abstract
Objective: Diabetic neuropathy is a common complication of diabetes mellitus. Patients with this disease suffer from various peripheral sensory symptoms that are not easily alleviated. We report on a case of a patient with diabetic neuropathy whose symptoms were alleviated after traditional Korean medical treatment.Methods: A patient with hand and foot numbness and coldness diagnosed with diabetic neuropathy was treated with Palmijihwang-tang (Bai Wei Di Huang Wa, 八味地黃湯) three times a day. The progress was evaluated with the numerical rating scale (NRS), neuropathy disability score (NDS), and neuropathy symptom score (NSS).Results: The improvement of symptoms appeared to be faster and more effective than that of conventional treatment. The improvement was observed from the second day of the treatment.Conclusions: This case study shows that Palmijihwang-tang may be an effective treatment for diabetic neuropathy.
Keywords
diabetic neuropathy; Korean medicine; herbal medicine; Bai Wei Di Huang Wa; Palmijihwang-tang;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012;6:CD007543.
2 Young RJ, Ewing DJ, Clarke BF. Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology. Diabetes Care 1988;11:34.   DOI
3 Müller-Stich BP, Fischer L, Kenngott HG, Gondan M, Senft J, Clemens G, et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization-results of a prospective cohort study (DiaSurg 1 study). Ann Surg 2013; 258(5):760.   DOI
4 Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83(1):85.   DOI
5 Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009;361:1963.   DOI
6 Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76(20):1758.   DOI
7 Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Chaudhry V, Stevens JC, Kincaid J, So YT. Practice Advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2006;66(12):1805.   DOI
8 Du HG. Oriental Internal Medicine(Kidney system). Seoul: The Oriental Medicine Institue; 1991, p. 939-50.
9 Seoul National University College of Medicine . Endocrinology. Seoul: Seoul National University Press; 1990, p. 225, 252-3.
10 Bronch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative morthalith in type I diabetes mellitus. diabetologia 1985;28:590-6.   DOI
11 Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 1992;15:1902-25.   DOI
12 Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984;15:2.   DOI
13 Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;11(6):521.   DOI
14 Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008;120(1):1.   DOI
15 Weintrob N, Amitay I, Lilos P, Shalitin S, Lazar L, Josefsberg Z. Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes. Journal of Diabetes and Its Complications 2007;21(1):13-9.   DOI
16 Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36(2):150.   DOI
17 Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869.   DOI
18 Martin CL, Albers JW, Pop-Busui R. DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014;37:31.   DOI
19 Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28(4):956.
20 Cho KH, Jung WS, Lee KJ. A case of Yukmijihwang-hwan’s effect on Diabetic neuropathy. The Society of Internal Korean Medicine 1999;20(1):286-90.